4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-015508
Director sold 25,000 shares at an average $10.30 ($257,450)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2024-05-31 | Sale 10b5-1 | −15,000 | $9.41 | $141,150 | 791,283 | D |
| Harmon Cyrus Director | 2024-06-03 | Sale 10b5-1 | −5,000 | $10.93 | $54,650 | 786,283 | D |
| Harmon Cyrus Director | 2024-06-04 | Sale 10b5-1 | −5,000 | $12.33 | $61,650 | 781,283 | D |
| Open-market sales · 25,000 sh · avg $10.30 · $257,450 | |||||||
Loading xslF345X05/form4-06042024_090601.xml…